Calvert Equity A CSIEX

Medalist Rating as of | See Eaton Vance Investment Hub
  • NAV / 1-Day Return 85.59  /  −0.16 %
  • Total Assets 6.9 Bil
  • Adj. Expense Ratio
    0.910%
  • Expense Ratio 0.910%
  • Distribution Fee Level Below Average
  • Share Class Type Front Load
  • Category Large Growth
  • Investment Style Large Growth
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 0.16%
  • Turnover 10%

USD | NAV as of Sep 27, 2024 | 1-Day Return as of Sep 27, 2024, 10:16 PM GMT+0

Morningstar’s Analysis CSIEX

Will CSIEX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Still an attractive larger-cap ESG vehicle for the long haul.

Senior Analyst William Samuel Rocco

William Samuel Rocco

Senior Analyst

Summary

Calvert Equity personnel and other strengths remain intact. It continues to be an appealing source of environmental, social, and governance exposure for patient investors who are comfortable with the drawbacks of its atypical approach as well as the benefits.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings CSIEX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 42.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Danaher Corp

4.87 336.1 Mil
Healthcare

Thermo Fisher Scientific Inc

4.85 334.7 Mil
Healthcare

Visa Inc Class A

4.82 332.6 Mil
Financial Services

Mastercard Inc Class A

4.60 317.3 Mil
Financial Services

Microsoft Corp

4.34 299.2 Mil
Technology

Alphabet Inc Class C

4.34 299.1 Mil
Communication Services

TJX Companies Inc

3.87 266.6 Mil
Consumer Cyclical

S&P Global Inc

3.84 265.0 Mil
Financial Services

Zoetis Inc Class A

3.67 253.1 Mil
Healthcare

Intuit Inc

3.54 244.1 Mil
Technology

Sponsor Center